TrialThe Journal of infectious diseases2024

A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults.

Carol M Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.